Brooks Laboratories Limited (NSE:BROOKS)
134.25
-0.91 (-0.67%)
Sep 30, 2025, 3:29 PM IST
Brooks Laboratories Revenue
Brooks Laboratories had revenue of 255.12M INR in the quarter ending June 30, 2025, with 42.26% growth. This brings the company's revenue in the last twelve months to 901.36M, up 10.30% year-over-year. In the fiscal year ending March 31, 2025, Brooks Laboratories had annual revenue of 825.57M with 3.86% growth.
Revenue (ttm)
901.36M
Revenue Growth
+10.30%
P/S Ratio
4.42
Revenue / Employee
2.79M
Employees
323
Market Cap
3.98B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 825.57M | 30.71M | 3.86% |
Mar 31, 2024 | 794.86M | 162.81M | 25.76% |
Mar 31, 2023 | 632.05M | -279.80M | -30.69% |
Mar 31, 2022 | 911.85M | 139.38M | 18.04% |
Mar 31, 2021 | 772.47M | 75.58M | 10.85% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |